Skip to main content
Fig. 4 | Orphanet Journal of Rare Diseases

Fig. 4

From: Fetal therapies and trials for lysosomal storage diseases: a survey of attitudes of parents and patients

Fig. 4

Attitudes toward participation in a clinical trial for fetal gene therapy. Respondents were asked the question “If you or your partner were to become pregnant and the fetus were diagnosed with MPS, enroll in a phase I clinical trial (to determine safety) for fetal gene therapy?” A All respondents (n = 138), B Comparison of respondents from the United States (n = 100) and the United Kingdom (n = 29) (p = 0.87, Fisher’s exact test), C Variables with statistical significance on univariate and multivariable regression. OR odds ratio, CI confidence interval, ERT enzyme replacement therapy

Back to article page